Non-interventional Study on Time to Response and Quality of Life in Relapsed/Refractory Multiple Myeloma When Treated With Lenalidomide in Second Line

This study is currently recruiting participants.

Verified September 2011 by Karolinska University Hospital

Study NCT01430546 Information provided by Karolinska University Hospital

First Received on September 7, 2011. No Changes Posted

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Multiple Myeloma

Additional conditions recognized in this trial

More general conditions related to this trial

Additional drug interventions recognized in this trial

Lenalidomide

More general drug interventions related to this trial

Sponsors listed in this trial

Hareth Nahi